KDM4B Regulates Replication Fork Stability During Replication Stress in Concert with Poly(ADP-ribose) Metabolism in Prostate Cancer

Background/Objectives: Poly(ADP-ribose) polymerase-1 (PARP1) and poly(ADP-ribose) glycohydrolase (PARG) coordinately regulate poly(ADP-ribose) (PAR) metabolism, which is essential for maintaining genome integrity during DNA replication. We investigated the role of the histone demethylase KDM4B in replication-fork protection and whether KDM4 inhibition could be exploited therapeutically in prostate cancer. Methods: The role of KDM4B in replication stress was examined in prostate cancer cells using genetic and pharmacological approaches. KDM4B interactions with PARG, stalled replication forks, and DNA fork structures were assessed using biochemical and molecular assays. Replication-fork stability, chromatin-associated proteins, PARylation, and DNA damage were evaluated following KDM4 inhibition. The therapeutic effects of combined KDM4 and PAR metabolism inhibition were assessed using the KDM4 inhibitor B3 together with the PARP inhibitor olaparib or the PARG inhibitor PDD00017273. Results: KDM4B interacted with PARG and localized to replication stress-associated ssDNA regions, where its depletion increased H3K9me3 accumulation and impaired PARG and XRCC1 accumulation. KDM4B directly bound fork-like DNA structures in vitro, and PARylation enhanced this interaction. Genetic depletion of KDM4B or pharmacological KDM4 inhibition disrupted replication stress responses, altered PAR signaling, and increased replication-associated DNA damage. Proteomic analysis using a synthetic Y-DNA probe revealed changes in the association of replication- and repair-related proteins following KDM4 inhibition. Combined treatment with B3 and either olaparib or PDD00017273 produced synergistic cytotoxicity in prostate cancer cells, particularly in the context of TP53/RB1 deficiency, with pronounced activity of the B3–PDD00017273 combination in HRR-proficient PC3 cells. Conclusions: These findings identify KDM4B as a regulator of replication stress responses and support a functional interplay between KDM4B and PAR metabolism in maintaining replication fork integrity. The synergistic cytotoxicity observed with combined KDM4 and PARP/PARG inhibition provides a rationale for further preclinical investigation, although the efficacy and tolerability of these combinations remain to be established in vivo.

Authors

Institutions

Publication Details

Journal
Pharmaceuticals
Published
2026-11-12
DOI
https://doi.org/10.3390/ph19111795
Primary Topic
PARP inhibition in cancer therapy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

KDM4B Regulates Replication Fork Stability During Replication Stress in Concert with Poly(ADP-ribose) Metabolism in Prostate Cancer

Jer‐Tsong Hsieh, Zhi‐Ping Liu, Lingling Duan, D. Bayona et al.
Pharmaceuticals
PARP inhibition in cancer therapy
article

KDM4B Regulates Replication Fork Stability During Replication Stress in Concert with Poly(ADP-ribose) Metabolism in Prostate Cancer

Jer‐Tsong Hsieh, Zhi‐Ping Liu, Lingling Duan, D. Bayona, Rey-Chen Pong
article en

Abstract

Background/Objectives: Poly(ADP-ribose) polymerase-1 (PARP1) and poly(ADP-ribose) glycohydrolase (PARG) coordinately regulate poly(ADP-ribose) (PAR) metabolism, which is essential for maintaining genome integrity during DNA replication. We investigated the role of the histone demethylase KDM4B in replication-fork protection and whether KDM4 inhibition could be exploited therapeutically in prostate cancer. Methods: The role of KDM4B in replication stress was examined in prostate cancer cells using genetic and pharmacological approaches. KDM4B interactions with PARG, stalled replication forks, and DNA fork structures were assessed using biochemical and molecular assays. Replication-fork stability, chromatin-associated proteins, PARylation, and DNA damage were evaluated following KDM4 inhibition. The therapeutic effects of combined KDM4 and PAR metabolism inhibition were assessed using the KDM4 inhibitor B3 together with the PARP inhibitor olaparib or the PARG inhibitor PDD00017273. Results: KDM4B interacted with PARG and localized to replication stress-associated ssDNA regions, where its depletion increased H3K9me3 accumulation and impaired PARG and XRCC1 accumulation. KDM4B directly bound fork-like DNA structures in vitro, and PARylation enhanced this interaction. Genetic depletion of KDM4B or pharmacological KDM4 inhibition disrupted replication stress responses, altered PAR signaling, and increased replication-associated DNA damage. Proteomic analysis using a synthetic Y-DNA probe revealed changes in the association of replication- and repair-related proteins following KDM4 inhibition. Combined treatment with B3 and either olaparib or PDD00017273 produced synergistic cytotoxicity in prostate cancer cells, particularly in the context of TP53/RB1 deficiency, with pronounced activity of the B3–PDD00017273 combination in HRR-proficient PC3 cells. Conclusions: These findings identify KDM4B as a regulator of replication stress responses and support a functional interplay between KDM4B and PAR metabolism in maintaining replication fork integrity. The synergistic cytotoxicity observed with combined KDM4 and PARP/PARG inhibition provides a rationale for further preclinical investigation, although the efficacy and tolerability of these combinations remain to be established in vivo.

PharmaceuticalsVol. 19(11)
The University of Texas Southwestern Medical Center (US)
Good health and well-being
PARP inhibition in cancer therapy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon